AzTrials
AzTrials

OtosclerosisNCT05799404

Stapes Footplate Thickness Measured With UHR-CT

An observational study of Otosclerosis and Otitis Media, run by Central Hospital, Nancy, France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to compare the thickness of the stapes footplate measured with ultra high resolution CT in control patients, otosclerosis patients and chronic otitis media patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Otosclerosis, Otitis Media
What is being tested?
ultra-high resolution CT
How many people
100 participants
Where
No sites listed yet
Study dates
28 Apr 2023to 28 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients refered to our department between october 2020 and October 2022 for an ultra high resolution CT of the temporal bone

Who may be able to join

  • Ultra high resolution CT of the temporal bone available

Who cannot join

  • previous surgery

Trial locations and contacts

No sites are listed yet.

romain gillet, MD contact

003383851811

r.gillet@chru-nancy.fr

About this study

The aim of this study is to compare the thickness of the stapes footplate measured with ultra high resolution CT in control patients, otosclerosis patients and chronic otitis media patients.

Read the detailed description

Stapes footplate thickness will be measured under its anterior crus, its posterior crus and at its midpoint, in both the stapes axial plane and the laletral semi-circular canal planes.

Being tested
ultra-high resolution CT
Keywords
ultra high resolution, ct, stapes, footplate, otosclerosis, otitis media
Medical subject headings
Otosclerosis, Otitis Media

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultra-high resolution CTDiagnostic test

    stapes footplate thickness measurement

Study groups in NCT05799404
Study groupRoleWhat they receive
otosclerosisotosclerosis patients
Receives: Diagnostic Test: ultra-high resolution CT
chronic otitis mediaotitis media with middle ear opacities
Receives: Diagnostic Test: ultra-high resolution CT
controlssudden ear loss, pre-implantatory imaging, vertigo, tympanic perforation
Receives: Diagnostic Test: ultra-high resolution CT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. stapes footplate thickness in mm in the stapes axial plane

    stapes footplate thickness measured with a digital caliper on our PACS system with the accuracy of a tenth of a millimetre, under the anterior crus of the stapes, under the posterior crus of the stapes, and at its midpoint, in the stapes axial plane and in the lateral semi circular canal plane, to compare both values and find out wich one is the most pertinent

    Measured: october 2020-october 2022

Secondary outcomes (1)
  1. interobserver variability

    interobserver variability

    Measured: october 2020-october 2022

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2023
  2. Study start28 Apr 2023 (estimated)
  3. Primary completion28 Jun 2023 (estimated)
  4. Study completion28 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05799404
Sponsor's protocol ID
N°3-RCB/EUDRACT
Status last verified
Apr 2023
First submitted
5 Dec 2022
Last updated
5 Apr 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Akazawa Y, Ganaha A, Higa T, Kondo S, Oyakawa Y, Hirakawa H, Suzuki M, Yamashiro T. Measurement of stapes footplate thickness in otosclerosis by ultra-high-resolution computed tomography. Acta Otolaryngol. 2020 Nov;140(11):899-903. doi: 10.1080/00016489.2020.1788225. Epub 2020 Jul 23.

    PubMed 32700991
  • Tang R, Yin H, Wang Z, Zhang Z, Zhao L, Zhang P, Li J, Zhao P, Lv H, Zhang L, Yang Z, Wang Z. Stapes visualization by ultra-high resolution CT in cadaveric heads: A preliminary study. Eur J Radiol. 2021 Aug;141:109786. doi: 10.1016/j.ejrad.2021.109786. Epub 2021 May 21.

    PubMed 34058698

Questions about this trial

What is this clinical trial studying?

An observational study of Otosclerosis and Otitis Media, run by Central Hospital, Nancy, France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact romain gillet, MD (003383851811, r.gillet@chru-nancy.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

stapes footplate thickness in mm in the stapes axial plane (time frame: october 2020-october 2022). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05799404, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in